Gregory Sorensen

657 total citations
15 papers, 434 citations indexed

About

Gregory Sorensen is a scholar working on Radiology, Nuclear Medicine and Imaging, Genetics and Cancer Research. According to data from OpenAlex, Gregory Sorensen has authored 15 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in Gregory Sorensen's work include Glioma Diagnosis and Treatment (7 papers), MRI in cancer diagnosis (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Gregory Sorensen is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), MRI in cancer diagnosis (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Gregory Sorensen collaborates with scholars based in United States, Norway and Israel. Gregory Sorensen's co-authors include Elizabeth R. Gerstner, Tracy T. Batchelor, Patrick Y. Wen, Kei Yamada, Ramón González, Hakan Ay, Lee H. Schwamm, Walter J. Koroshetz, F S Buonanno and Guy Rordorf and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

Gregory Sorensen

14 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory Sorensen United States	10	175	163	132	129	107	15	434
Cordula Scherlach Germany	15	108 0.6×	109 0.7×	132 1.0×	143 1.1×	240 2.2×	42	510
Catherine Pinelli France	8	128 0.7×	210 1.3×	297 2.3×	168 1.3×	163 1.5×	10	520
Greg Fitt Australia	10	102 0.6×	83 0.5×	121 0.9×	90 0.7×	66 0.6×	16	401
Melanie Barz Germany	14	104 0.6×	128 0.8×	232 1.8×	79 0.6×	79 0.7×	40	468
Ian Kamaly-Asl United Kingdom	15	201 1.1×	151 0.9×	274 2.1×	83 0.6×	197 1.8×	42	737
Jorge A. Gutiérrez United States	9	257 1.5×	130 0.8×	234 1.8×	114 0.9×	96 0.9×	24	640
Vincent Cheung United States	7	173 1.0×	127 0.8×	343 2.6×	131 1.0×	101 0.9×	13	510
Franziska Vettermann Germany	13	243 1.4×	151 0.9×	324 2.5×	70 0.5×	101 0.9×	23	539
Joe X Qiao United States	8	472 2.7×	140 0.9×	202 1.5×	161 1.2×	72 0.7×	17	646
David Coope United Kingdom	13	214 1.2×	131 0.8×	255 1.9×	59 0.5×	126 1.2×	44	536

Countries citing papers authored by Gregory Sorensen

Since Specialization

Citations

This map shows the geographic impact of Gregory Sorensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Sorensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Sorensen more than expected).

Fields of papers citing papers by Gregory Sorensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Sorensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Sorensen. The network helps show where Gregory Sorensen may publish in the future.

Co-authorship network of co-authors of Gregory Sorensen

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Sorensen. A scholar is included among the top collaborators of Gregory Sorensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Sorensen. Gregory Sorensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Magid-Bernstein, Jessica, Hannah E. Beatty, Rachel Choi, et al.. (2025). Early CSF inflammatory markers after aneurysmal subarachnoid hemorrhage and their relationship to disease severity and shunt placement. Journal of Stroke and Cerebrovascular Diseases. 34(9). 108395–108395.

Ratai, Eva‐Maria, Zheng Zhang, James R. Fink, et al.. (2018). ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy. PLoS ONE. 13(6). e0198548–e0198548. 20 indexed citations

Barboriak, Daniel P., Zheng Zhang, Bradley S. Snyder, et al.. (2018). Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 Study. Radiology. 290(2). 467–476. 15 indexed citations

Ly, Ina, Kyrre E. Emblem, Yangming Ou, et al.. (2018). Probing tumor microenvironment in patients with newly diagnosed glioblastoma during chemoradiation and adjuvant temozolomide with functional MRI. Scientific Reports. 8(1). 17062–17062. 9 indexed citations

Andronesi, Ovidiu C., Morteza Esmaeili, Ronald Borra, et al.. (2017). Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival. npj Precision Oncology. 1(1). 13 indexed citations

Emblem, Kyrre E., Elizabeth R. Gerstner, Gregory Sorensen, et al.. (2016). Abstract 3975: Matrix-depleting anti-hypertensives decompress tumor blood vessels and improve perfusion in patients with glioblastomas receiving anti-angiogenic therapy. Cancer Research. 76(14_Supplement). 3975–3975. 5 indexed citations

Gerstner, Elizabeth R., Kyrre E. Emblem, & Gregory Sorensen. (2015). Vascular Magnetic Resonance Imaging in Brain Tumors During Antiangiogenic Therapy—Are We There Yet?. The Cancer Journal. 21(4). 337–342. 6 indexed citations

Gerstner, Elizabeth R., Zheng Zhang, James R. Fink, et al.. (2015). ACRIN 6684: Assessment of tumor hypoxia in newly diagnosed GBM using FMISO PET and MRI.. Journal of Clinical Oncology. 33(15_suppl). 2024–2024. 1 indexed citations

Menon, Lata G., et al.. (2011). Imaging of human mesenchymal stromal cells: homing to human brain tumors. Journal of Neuro-Oncology. 107(2). 257–267. 26 indexed citations

10.

Gerstner, Elizabeth R., et al.. (2010). Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib. Neuro-Oncology. 12(5). 466–72. 104 indexed citations

11.

Batchelor, Tracy T., Gregory Sorensen, Emmanuelle di Tomaso, et al.. (2008). Abstract LB-247: A multidisciplinary phase II study of AZD2171 (cediranib), an oral pan-VEGF receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma. Cancer Research. 68(9_Supplement). LB–247. 9 indexed citations

12.

Slattery, William H., et al.. (2003). Magnetic Resonance Imaging Scanner Reliability for Measuring Changes in Vestibular Schwannoma Size. Otology & Neurotology. 24(4). 666–671. 25 indexed citations

13.

Boas, David A., et al.. (1999). <title>Preliminary investigation into the use of diffuse optical tomography for monitoring and imaging stroke</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 3712. 56–61. 1 indexed citations

14.

Ay, Hakan, F S Buonanno, Guy Rordorf, et al.. (1999). Normal diffusion-weighted MRI during stroke-like deficits. Neurology. 52(9). 1784–1784. 190 indexed citations

15.

Campbell, William W., et al.. (1978). Linear Nevus Sebaceous Syndrome: Neurological Aspects Documented by Brain Scans Correlated with Developmental History and Radiographic Studies. Military Medicine. 143(3). 175–178. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact